Hyperimmunoglobulin E syndrome type 2D82.4

Last updated on: 13.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

ClassificationThis section has been translated automatically.

Genetic heterogeneity of hyper IgE recurrent infection syndrome.

  • HIES1 (147060) caused by an autosomal dominant mutation in the STAT3 gene (102582
  • HIES2 (243700) caused by a mutation in the DOCK8 gene (611432),
  • HIES3 (618282) caused by a mutation in the ZNF341 gene (618269),
  • HIES4A (619752) and HIES4B (618523), both caused by a mutation in the IL6ST gene (600694),
  • HIES5 (618944), caused by a mutation in the IL6R gene (147880).

EtiopathogenesisThis section has been translated automatically.

AR-HIES is inherited in an autosomal recessive manner and is caused by mutations in the DOCK8 gene.Hyper-IgE recurrent infection syndrome 2 is related to immunodeficiency syndrome 35.

Differential diagnosisThis section has been translated automatically.

Autosomal dominant hyper-IgE syndrome 1 (HIES1; 147060) is a primary immunodeficiency disease characterized by recurrent Staphylococcus aureus skin abscesses, elevated serum IgE, and abnormalities of connective tissue, skeleton, and dentition (Buckley et al., 1972; Grimbacher et al.1999).

Autosomal recessive hyper-IgE syndrome 2 (HIES2) also has hyper-IgE, eosinophilia, and recurrent staphylococcal infections, but differs from autosomal dominant HIES1 in the absence of connective tissue and skeletal involvement (Renner et al., 2004). See also TYK2 deficiency (611521), a clinically distinct disease entity that has characteristic features of both autosomal recessive HIES2 and Mendelian susceptibility to mycobacterial disease (MSMD; 209950) (Minegishi et al., 2006).

LiteratureThis section has been translated automatically.

  1. Asano T et al (2021) Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med 218: e20202592.
  2. Buckley RH et al (1972) Extreme hyperimmunoglobulin E and susceptibility to infection. Pediatrics 49: 59-70.
  3. Grimbacher B et al (1999) Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. New Eng J Med 340: 692-702.
  4. Milner JD et al (2008) Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452: 773-776.
  5. Hoger PH et al (1985) Craniosynostosis in hyper-IgE-syndrome. Europ. J. Pediat. 144: 414-417
  6. Minegishi Y et al (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25: 745-755.
  7. Zhang Q et al (2009) Combined immunodeficiency associated with DOCK8 mutations. New Eng J Med 361: 2046-2055.

Last updated on: 13.04.2022